Williams, Austin D.
Khan, Atif J.
Sevilimedu, Varadan
Barrio, Andrea V.
Morrow, Monica
Mamtani, Anita
Funding for this research was provided by:
NIH/NCI Cancer Center Support Grant (P30CA008748)
Article History
Received: 13 April 2022
Accepted: 30 June 2022
First Online: 11 August 2022
Disclosures
: Dr. Monica Morrow has received honoraria from Exact Sciences and Roche. Dr. Atif J. Khan has received honoraria from Exact Sciences, and owns stock in Novavax and Xtrava. All other authors have no conflict of interest disclosures to report.